
    
      This study is an open-label, interventional, retrospective, multicenter, international study,
      single-arm, non-randomized, and non-controlled study. The subject's trial participation
      includes a single visit. During the visit, subjects who give consent to participate in the
      trial will undergo blood sampling for genetic markers testing and retrospective data will be
      collected relative to the first year of the subject's r-hGH treatment.

      The r-hGH treatment followed by the subject is indicated the pediatric population, therefore
      most of the subjects included into the trial will be below 18 years old.

      This study is a non-investigational medicinal product (IMP) trial therefore no drug product
      data is provided.
    
  